SBIR/STTR Research Award
Antiinfection Agents that Target Protein Synthesis
Award amount
$99,999Program and phase
SBIR · Phase IAward year
2006Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PINNACLE PHARMACEUTICALS
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2006-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Inhibition of protein synthesis is a validated target for the identification of compounds having antibacterial activity. This reflects the reality that protein synthesis is an essential process in prokaryotes, and such organisms employ protein synthesizing systems that differ in many respects from those in eukaryotes. By focusing on a single molecular locus unique to bacteria, Pinnacle has identified a process in bacterial protein synthesis that can be inhibited uniquely and has developed a high throughput assay to permit the identification of natural products that target this prokaryotic locus. Limited screening of natural products extracts has identified several species capable of targeting E. coli protein synthesis. The specific aims of the present proposal include more extensive screening to identify potent and selective inhibitors of the prokaryotic enzyme and characterization of the active agents.
Technology keywords
Not reported